APA (7th ed.) Citation

Basilion, J. P., Schievella, A. R., Burns, E., Rioux, P., Olson, J. C., Monia, B. P., . . . Housman, D. E. (1999). Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy. Molecular pharmacology, 56(2), 359-369. https://doi.org/10.1016/S0026-895X(24)12646-6

Chicago Style (17th ed.) Citation

Basilion, James P., Andrea R. Schievella, Erica Burns, Patrice Rioux, Jeffrey C. Olson, Brett P. Monia, Kristina M. Lemonidis, Vincent P. Stanton, and David E. Housman. "Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy." Molecular Pharmacology 56, no. 2 (1999): 359-369. https://doi.org/10.1016/S0026-895X(24)12646-6.

MLA (9th ed.) Citation

Basilion, James P., et al. "Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy." Molecular Pharmacology, vol. 56, no. 2, 1999, pp. 359-369, https://doi.org/10.1016/S0026-895X(24)12646-6.